ArticleIranian journal of public health2022
Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017.
Article in Iranian journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 15 citations in OpenAlex.
- Patient perceptions of integrated cardiovascular care in primary healthcare settings in Kazakhstan.Future science OA · 2026Article
- Serum potassium and sodium levels and nutrient intake in population exposed to radiation from the Semipalatinsk nuclear test site.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026Article
- A pilot genome-wide association study of ischemic heart disease with co-occurring arterial hypertension in a Kazakh cohort.Frontiers in genetics · 2026Article
- Prevalence and risk factors of cardiovascular diseases among youths in Kazakhstan: a systematic review of the literature.Future science OA · 2025Review
- Genetic Associations ofDiagnostics (Basel, Switzerland) · 2024Article
- Temporal Trends and Mortality Patterns in Peripheral Arterial Disease: A Comprehensive Analysis of Hospitalized Patients in Kazakhstan between 2014 and 2021.Journal of epidemiology and global health · 2024Article
- Economic and healthcare influences on circulatory diseases in Kazakhstan: a retrospective ecological study.Journal of health, population, and nutrition · 2024Article
- May Measurement Month 2021: an analysis of blood pressure screening results from Kazakhstan.European heart journal supplements : journal of the European Society of Cardiology · 2024Article
- Examining a 12-year experience within Kazakhstan's national heart transplantation program.Scientific reports · 2024Article
- Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021.International journal of health policy and management · 2024Article
- Examining disparities in cardiovascular disease prevention strategies and incidence rates between urban and rural populations: insights from Kazakhstan.Scientific reports · 2023Article
- Recent Trends in Cardiovascular Disease Mortality in Kazakhstan.Vascular health and risk management · 2023Article
- Neuropsychological Assessment of Community-Dwelling Older Adults in Almaty, Kazakhstan.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aimed to evaluate the impact of national health programs implemented in Kazakhstan from 2011 on CVD incidence and mortality. Methods: Incidence and mortality rates from CVD were studied in Kazakhstan from 2004 to 2017. The official data obtained from "Medinform" company were analyzed based on the annual population statistics. Results: There was an increase in the incidence of cardiovascular disease among the population of Kazakhstan from 1845.4 per 100,000 in 2004 to 2597.5 per 100,000 in 2017. This might be attributed to the implementation of the national health programs, which improved early CVD identification. Incidence of ischemic heart disease (IHD) was grown almost in all provinces of Kazakhstan during the study period. The mortality from cardiovascular disease had a considerable decline over the study period, in particular after 2010, it might be influenced by early diagnosis and provision of timely treatment. Conclusion: The experience of Kazakhstan national health programs shows improved identification of CVD and IHD and timely treatment for cardiovascular disease. A significant variation in incidence and mortality rates of cardiovascular disease was observed between the country provinces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.